BB vs SLRX · P/E 117, rev $549.1M vs $4.9M cap
BlackBerry Ltd (BB) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
BB currently screens at market cap $6.14B and trailing P/E 116.5. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the BB and SLRX stock pages for the full models.
Not investment advice.